FDA issued a Warning Letter to Chongqing Lummy Pharmaceutical Co. Ltd. on 6/21/2016 as a result of this inspection.
483 Chongqing Lummy Pharmaceutical Mar 2016

483 Chongqing Lummy Pharmaceutical Mar 2016

Peter Baker FDA$119.00 - Available Now

FDA investigators audited the Chongqing Lummy Pharmaceutical - Chongqing, China facility and issued 2 inspectional observations (via FDA 483) on 17 Mar 2016.

Product details

  • Category: Human Drugs
  • Number of Observations: 2
  • Inspection end: 17 Mar 2016
  • Location: Chongqing, China
  • FEI: 3006560479
Add To Cart